Response to Letter to “Relationship between maternal mortality and ritodrine hydrochloride as a tocolytic agent in Japan”
Journal of Obstetrics and Gynaecology Research · 2024
DOI: 10.1111/jog.15999 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2024. Verfasst von Masamitsu Nakamura und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Fujita Health University, Aichi, Japan. Hauptthemen laut MEDLINE: Tocolytic Agents, Ritodrine, Maternal Mortality. Die Arbeit nennt 1 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Fujita Health University, Aichi, Japan.
- Department of Obstetrics and Gynecology, Showa University School of Medicine, Tokyo, Japan.
- Department of Obstetrics and Gynecology, St. Marianna School of Medicine, Kanagawa, Japan.
ORCID-Profile: Masamitsu Nakamura
Zitieren
APA
Nakamura, M., Sekizawa, A., Hasegawa, J., & Maternal Death Exploratory Committee in Japan (2024). Response to Letter to “Relationship between maternal mortality and ritodrine hydrochloride as a tocolytic agent in Japan”. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.15999
Vancouver
Nakamura M, Sekizawa A, Hasegawa J, Maternal Death Exploratory Committee in Japan. Response to Letter to “Relationship between maternal mortality and ritodrine hydrochloride as a tocolytic agent in Japan”. Journal of Obstetrics and Gynaecology Research. 2024. doi:10.1111/jog.15999
BibTeX
@article{Nakamura2024,
author = {Nakamura, Masamitsu and Sekizawa, Akihiko and Hasegawa, Junichi and Maternal Death Exploratory Committee in Japan, Maternal Death Exploratory Committee in Japan},
title = {Response to Letter to “Relationship between maternal mortality and ritodrine hydrochloride as a tocolytic agent in Japan”},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2024},
doi = {10.1111/jog.15999}
}
EUVIMED